Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors

被引：0
作者：
Diane L Reidy
Laura H Tang
Leonard B Saltz
机构：
[1] DL Reidy is Assistant Attending Physician,
[2] LH Tang is Assistant Attending Pathologist and LB Saltz is an Attending Physician,undefined
[3] all at the Memorial Sloan–Kettering Cancer Center and Weill Medical College of Cornell University,undefined
[4] New York,undefined
[5] NY,undefined
[6] USA.,undefined
来源：
Nature Reviews Clinical Oncology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Well-differentiated neuroendocrine tumors (NET) are usually slow-growing cancers even when they exhibit local invasion or metastases. Surgery is curative in a minority of patients and systemic chemotherapy is minimally effective. Important cellular processes involved in the pathogenesis of NET have now been identified. In this Review, Reidy et al. discuss the data regarding therapies currently used for treating well-differentiated NETs and the strategies being used in clinical trials.
引用
收藏
页码：143 / 152
页数：9
相关论文
共 84 条
[1]  
Moertel CG(1991)Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms Cancer 68 227-232
[2]  
Modlin IM(2006)The functional characterization of normal and neoplastic human enterochromaffin cells J Clin Endocrinol Metab 91 2340-2348
[3]  
Rindi G(2007)Prognostic factors in gastrointestinal endocrine tumors Endocr Pathol 18 145-149
[4]  
Ferrone CR(2007)Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol 25 5609-5615
[5]  
Van Eeden S(2002)Classification of low-grade neuroendocrine tumors of midgut and unknown origin Hum Pathol 33 1126-1132
[6]  
Rindi G(2007)TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system Virchows Arch 451 757-762
[7]  
Schurr P(2007)Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience Ann Surg 245 273-281
[8]  
Touzios JG(2005)Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241 776-783
[9]  
Sarmiento JM(2003)Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival J Am Coll Surg 197 29-37
[10]  
Chamberlain RS(2000)Hepatic neuroendocrine metastases: does intervention affect outcome? J Am Coll Surg 190 432-445
123456789